Obesity

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
THT 2025: The SUMMIT Trial

Barry Borlaug

Watch time: 6m 31s
AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s
AHA 24: The SELECT Trial

Subodh Verma

Watch time: 5m 7s
AHA 24 Late-Breaking Discussion: The SUMMIT Trial

Harriette Van Spall, Milton Packer

Watch time: 17m 22s
AHA 24 Late-Breaking Discussion: The FLOW Trial

Harriette Van Spall,

Watch time: 16m 57s

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar

Joost Daemen, Nicolas M Van Mieghem

HFSA 24: STEP-HFpEF: Exercise Function and Frailty Status

Mikhail Kosiborod

Watch time: 12m 9s
HFSA 24: The HuMAIN-HFpEF Trial

Ambarish Pandey

Watch time: 4m 5s
EASD 24: Prespecified Analysis from the SELECT Trial

Helen Colhoun

Watch time: 5m 37s
Glucagon-Containing Dual and Triple Agonists For Obesity and MASH

Scott Harris

Watch time: 8m 36s

Lee Kaplan, Fatima Cody Stanford, Filip Knop, et al

Andrew JS Coats, Stefan Anker

Fausto J Pinto, John Spertus et al

Alberto Lorenzatti , Peter P Toth

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Nocturnal Hypertension

Roland Asmar, , , et al

Watch time: 1h 9m 26s

Yassir Javaid et al

Watch time: 18m 47s (4 videos)

Dennis V Cokkinos , Christos Belogianneas

Joost Daemen, Nicolas M Van Mieghem

Harold Bays, Naveed Sattar, Lydia Alexander, et al

Abhiram Prasad

Jack Wei Chieh Tan , Leong Chai Leow , Serene Wong , et al

Read time: 15m

Gurushankar Govindarajan , James R Sowers , Craig S Stump

About

The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
 

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

Fausto J Pinto, John Spertus et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
EP 87: Gut Microbiome and Heart Health: The 3 Compounds You Need to Know About with Dr Vuyisich

Ankur Kalra, Momchilo Vuyisich,

Listen time: 45m 50s

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day Two

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
e-SPACE CRM 2023 – Day One

Stefan Anker, Javed Butler, Antonio Ceriello, et al

Media

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer

Watch time: 1h 5m 20s
ACC.24: The STEP HFpEF DM Trial

Mikhail Kosiborod

Watch time: 6m 41s
View from the Thoraxcenter: ACC.24 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 43m 48s
HFA 24 Late-Breaker Discussion: Insights from the STEP-HFpEF

Harriette Van Spall, Mikhail Kosiborod

Watch time: 12m 4s
AHA 24: 3 Trials That Will Change My Practice

Michelle Kittleson

Watch time: 10m 27s
THT 2025: The SUMMIT Trial

Barry Borlaug

Watch time: 6m 31s

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
AOM 2024

Harold Bays, Naveed Sattar, Mikhail Kosiborod, et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar

Joost Daemen, Nicolas M Van Mieghem

Articles

Maternal Cardiac Function in Pregnancies With Metabolic Disorders

Deesha Patel

,

Makrina D Savvidou

,

Published:

19 June 2024

Citation:

European Cardiology Review 2024;19:e08.

DOI:

https://doi.org/10.15420/ecr.2023.28
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 485
  • Downloads: Downloads 21
  • Read time: 22m 59s

Treatment Options and Continuity of Care in MAFLD

Carmen Lara-Romero

,

Manuel Romero-Gómez

,

Published:

19 June 2024

Citation:

European Cardiology Review 2024;19:e06.

DOI:

https://doi.org/10.15420/ecr.2023.34
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1660
  • Downloads: Downloads 41
  • Citations: 6
  • Read time: 20m 32s

Link Between NAFLD/NASH and Cardiometabolic Syndrome

Sheila Gato

,

Vanessa García-Fernández

,

Antonio Gil-Gómez

,

Ángela Rojas

,

Rocío Montero-Vallejo

,

Rocío Muñoz-Hernández

,

Manuel Romero-Gómez

,

Published:

09 May 2024

Citation:

European Cardiology Review 2024;19:e03.

DOI:

https://doi.org/10.15420/ecr.2023.26
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 836
  • Downloads: Downloads 45
  • Citations: 3
  • Read time: 20m 25s

APSC Consensus on OSA in CVD Patients

Jack Wei Chieh Tan

,

Leong Chai Leow

,

Serene Wong

,

See Meng Khoo

,

Takatoshi Kasai

,

Pipin Kojodjojo

,

Duong-Quy Sy

,

Chuen Peng Lee

,

Naricha Chirakalwasan

,

Hsueh-Yu Li

,

Natalie Koh

,

Adeline Tan

,

Thun How Ong

,

Aye Thandar Aung

,

Song Tar Toh

,

Chi-Hang Lee

,

Published:

20 June 2022

Citation:

European Cardiology Review 2022;17:e16.

DOI:

https://doi.org/10.15420/ecr.2021.59
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 2000
  • Downloads: Downloads 88
  • Citations: 4
  • Read time: 15m